Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Full of News, but Worth a 15% Gain? (Amylin)
Full of News, but Worth a 15% Gain? (Amylin)
Full of News, but Worth a 15% Gain? (Amylin)
Submitted by
admin
on October 22, 2011 - 12:27pm
Source:
Motley Fool
News Tags:
Amylin
Byetta
diabetes
Novo Nordisk
Victoza
Headline:
Full of News, but Worth a 15% Gain? (Amylin)
Do Not Allow Advertisers to Use My Personal information
